- call +1-201-465-4211
- email sales@mrinsights.biz
Acinetobacter is a group of bacteria commonly found in soil and water. While there are many types or “species” of Acinetobacter and all can cause human disease, Acinetobacter baumannii accounts for about 80% of reported infections.
Outbreaks of Acinetobacter infections typically occur in intensive care units and healthcare settings housing very ill patients. Acinetobacter infections rarely occur outside of healthcare settings.
Acinetobacter is often resistant to many commonly prescribed antibiotics. Decisions on treatment of infections with Acinetobacter should be made on a case-by-case basis by a healthcare provider. Acinetobacter infection typically occurs in ill patients and can either cause or contribute to death in these patients.
Scope of the Report:
In the last several years, global market of Acinetobacter Infections Treatment developed rapidly, with an average growth rate of 2.96%. In 2016, United States Market Size of Acinetobacter Infections Treatment is nearly 22 M USD. For developing product, there are 1 in Phase III, 1 in Phase Ⅱ, 4 in Phase 1 and 8 in Preclinical. The total investment for Acinetobacter Infections Treatmen Drugs developing is around 90 M USD.
The global average Cost of Acinetobacter Infections Treatment is in the decreasing trend, from 2901 USD/Case in 2012 to2870 USD/Case in 2016. With the situation of global economy, prices will be in decreasing trend in the following five years.
The classification of Acinetobacter Infections Treatment includes Sulbactam, Carbapenems , Aminoglycosides, Polymyxins, Tigecycline and Others Treatment, and the proportion of Aminoglycosides in 2016 is about 18%, and the proportion is in decreasing trend from 2012 to 2016.
The worldwide market for Acinetobacter Infections Treatment is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2024, from xx million US$ in 2019, according to a new study.
This report focuses on the Acinetobacter Infections Treatment in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Entasis Therapeutics
Roche
Adenium Biotech
Vaxdyn
Hsiri Therapeutics
Aridis Pharmaceuticals
LegoChem Biosciences
Atterx Biotherapeutics
Achaogen
Peptilogics
Sealife PHARMA
Shionogi
Techulon
Tetraphase Pharmaceuticals
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Sulbactam
Carbapenems
Aminoglycosides
Polymyxins
Tetracyclines
Others
Market Segment by Applications, can be divided into
Application I
Application II
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Acinetobacter Infections Treatment product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Acinetobacter Infections Treatment, with price, sales, revenue and global market share of Acinetobacter Infections Treatment in 2017 and 2018.
Chapter 3, the Acinetobacter Infections Treatment competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Acinetobacter Infections Treatment breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Acinetobacter Infections Treatment market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Acinetobacter Infections Treatment sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Acinetobacter Infections Treatment Introduction
1.2 Market Analysis by Type
1.2.1 Sulbactam
1.2.2 Carbapenems
1.2.3 Aminoglycosides
1.2.4 Polymyxins
1.2.5 Tetracyclines
1.2.6 Others
1.3 Market Analysis by Applications
1.3.1 Application I
1.3.2 Application II
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Entasis Therapeutics
2.1.1 Business Overview
2.1.2 Acinetobacter Infections Treatment Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Entasis Therapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Roche
2.2.1 Business Overview
2.2.2 Acinetobacter Infections Treatment Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Roche Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Adenium Biotech
2.3.1 Business Overview
2.3.2 Acinetobacter Infections Treatment Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Adenium Biotech Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Vaxdyn
2.4.1 Business Overview
2.4.2 Acinetobacter Infections Treatment Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Vaxdyn Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Hsiri Therapeutics
2.5.1 Business Overview
2.5.2 Acinetobacter Infections Treatment Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Hsiri Therapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Aridis Pharmaceuticals
2.6.1 Business Overview
2.6.2 Acinetobacter Infections Treatment Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Aridis Pharmaceuticals Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 LegoChem Biosciences
2.7.1 Business Overview
2.7.2 Acinetobacter Infections Treatment Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 LegoChem Biosciences Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.8 Atterx Biotherapeutics
2.8.1 Business Overview
2.8.2 Acinetobacter Infections Treatment Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Atterx Biotherapeutics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.9 Achaogen
2.9.1 Business Overview
2.9.2 Acinetobacter Infections Treatment Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Achaogen Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.10 Peptilogics
2.10.1 Business Overview
2.10.2 Acinetobacter Infections Treatment Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Peptilogics Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.11 Sealife PHARMA
2.11.1 Business Overview
2.11.2 Acinetobacter Infections Treatment Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Sealife PHARMA Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.12 Shionogi
2.12.1 Business Overview
2.12.2 Acinetobacter Infections Treatment Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Shionogi Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.13 Techulon
2.13.1 Business Overview
2.13.2 Acinetobacter Infections Treatment Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Techulon Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.14 Tetraphase Pharmaceuticals
2.14.1 Business Overview
2.14.2 Acinetobacter Infections Treatment Type and Applications
2.14.2.1 Product A
2.14.2.2 Product B
2.14.3 Tetraphase Pharmaceuticals Acinetobacter Infections Treatment Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Acinetobacter Infections Treatment Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Acinetobacter Infections Treatment Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Acinetobacter Infections Treatment Manufacturer Market Share in 2018
3.3.2 Top 6 Acinetobacter Infections Treatment Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Acinetobacter Infections Treatment Market Analysis by Regions
4.1 Global Acinetobacter Infections Treatment Sales, Revenue and Market Share by Regions
4.1.1 Global Acinetobacter Infections Treatment Sales and Market Share by Regions (2014-2019)
4.1.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Regions (2014-2019)
4.2 North America Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
4.3 Europe Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
4.5 South America Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
5 North America Acinetobacter Infections Treatment by Country
5.1 North America Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
5.1.1 North America Acinetobacter Infections Treatment Sales and Market Share by Country (2014-2019)
5.1.2 North America Acinetobacter Infections Treatment Revenue and Market Share by Country (2014-2019)
5.2 United States Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
5.3 Canada Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
5.4 Mexico Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
6 Europe Acinetobacter Infections Treatment by Country
6.1 Europe Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
6.1.1 Europe Acinetobacter Infections Treatment Sales and Market Share by Country (2014-2019)
6.1.2 Europe Acinetobacter Infections Treatment Revenue and Market Share by Country (2014-2019)
6.2 Germany Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
6.3 UK Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
6.4 France Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
6.5 Russia Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
6.6 Italy Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
7 Asia-Pacific Acinetobacter Infections Treatment by Country
7.1 Asia-Pacific Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Acinetobacter Infections Treatment Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Acinetobacter Infections Treatment Revenue and Market Share by Country (2014-2019)
7.2 China Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
7.3 Japan Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
7.4 Korea Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
7.5 India Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
8 South America Acinetobacter Infections Treatment by Country
8.1 South America Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
8.1.1 South America Acinetobacter Infections Treatment Sales and Market Share by Country (2014-2019)
8.1.2 South America Acinetobacter Infections Treatment Revenue and Market Share by Country (2014-2019)
8.2 Brazil Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
8.3 Argentina Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
8.4 Colombia Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
9 Middle East and Africa Acinetobacter Infections Treatment by Countries
9.1 Middle East and Africa Acinetobacter Infections Treatment Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Acinetobacter Infections Treatment Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Acinetobacter Infections Treatment Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
9.3 Turkey Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
9.4 Egypt Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
9.5 Nigeria Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
9.6 South Africa Acinetobacter Infections Treatment Sales and Growth Rate (2014-2019)
10 Global Acinetobacter Infections Treatment Market Segment by Type
10.1 Global Acinetobacter Infections Treatment Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Acinetobacter Infections Treatment Sales and Market Share by Type (2014-2019)
10.1.2 Global Acinetobacter Infections Treatment Revenue and Market Share by Type (2014-2019)
10.2 Sulbactam Sales Growth and Price
10.2.1 Global Sulbactam Sales Growth (2014-2019)
10.2.2 Global Sulbactam Price (2014-2019)
10.3 Carbapenems Sales Growth and Price
10.3.1 Global Carbapenems Sales Growth (2014-2019)
10.3.2 Global Carbapenems Price (2014-2019)
10.4 Aminoglycosides Sales Growth and Price
10.4.1 Global Aminoglycosides Sales Growth (2014-2019)
10.4.2 Global Aminoglycosides Price (2014-2019)
10.5 Polymyxins Sales Growth and Price
10.5.1 Global Polymyxins Sales Growth (2014-2019)
10.5.2 Global Polymyxins Price (2014-2019)
10.6 Tetracyclines Sales Growth and Price
10.6.1 Global Tetracyclines Sales Growth (2014-2019)
10.6.2 Global Tetracyclines Price (2014-2019)
10.7 Others Sales Growth and Price
10.7.1 Global Others Sales Growth (2014-2019)
10.7.2 Global Others Price (2014-2019)
11 Global Acinetobacter Infections Treatment Market Segment by Application
11.1 Global Acinetobacter Infections Treatment Sales Market Share by Application (2014-2019)
11.2 Application I Sales Growth (2014-2019)
11.3 Application II Sales Growth (2014-2019)
12 Acinetobacter Infections Treatment Market Forecast (2019-2024)
12.1 Global Acinetobacter Infections Treatment Sales, Revenue and Growth Rate (2019-2024)
12.2 Acinetobacter Infections Treatment Market Forecast by Regions (2019-2024)
12.2.1 North America Acinetobacter Infections Treatment Market Forecast (2019-2024)
12.2.2 Europe Acinetobacter Infections Treatment Market Forecast (2019-2024)
12.2.3 Asia-Pacific Acinetobacter Infections Treatment Market Forecast (2019-2024)
12.2.4 South America Acinetobacter Infections Treatment Market Forecast (2019-2024)
12.2.5 Middle East and Africa Acinetobacter Infections Treatment Market Forecast (2019-2024)
12.3 Acinetobacter Infections Treatment Market Forecast by Type (2019-2024)
12.3.1 Global Acinetobacter Infections Treatment Sales Forecast by Type (2019-2024)
12.3.2 Global Acinetobacter Infections Treatment Market Share Forecast by Type (2019-2024)
12.4 Acinetobacter Infections Treatment Market Forecast by Application (2019-2024)
12.4.1 Global Acinetobacter Infections Treatment Sales Forecast by Application (2019-2024)
12.4.2 Global Acinetobacter Infections Treatment Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Acinetobacter Infections Treatment Picture
Table Product Specifications of Acinetobacter Infections Treatment
Figure Global Sales Market Share of Acinetobacter Infec
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
